Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Molluscum Contagiosum

Trial Profile

A Multicenter, Randomized, Double-Blind, Vehicle-Controlled Phase II Study to Evaluate the Efficacy, Tolerability, and Safety of VBP-245 in Pediatric Subjects for the Treatment of Molluscum Contagiosum

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2018

At a glance

  • Drugs Povidone iodine (Primary)
  • Indications Molluscum contagiosum
  • Focus Therapeutic Use
  • Sponsors Veloce BioPharma
  • Most Recent Events

    • 09 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 31 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Jun 2018.
    • 31 Jan 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top